EcoDrugPlus

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSSAUG00010015907
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSSAUG00010026271
Gene Symbol: LOC115576941
3 Cross references
193 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSSAUG00010011906
Gene Symbol: LOC115571882
2 Cross references
172 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSSAUG00010020406
Gene Symbol: TLR2
3 Cross references
183 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSSAUG00010015548
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSSAUG00010015546
Gene Symbol: TLR8
1 Cross references
187 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSSAUG00010006061
Gene Symbol: LOC115590525
3 Cross references
213 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSAUG00010019056
Gene Symbol: TAAR1
3 Cross references
335 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSAUG00010006021
Gene Symbol: TAAR1
1 Cross references
366 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSSAUG00010018562
Gene Symbol: TGFBR1B
1 Cross references
204 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSSAUG00010021525
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Transthyretin-Like

Ensembl ID : ENSSAUG00010007903
Gene Symbol: LOC115590906
3 Cross references
178 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).